Huma appoints Shahram Sharif as Chief Business Officer - Medtech to accelerate digital-first use in the medtech industry

First published:
December 14, 2021
mins read
Ed Sykes

Healthtech company Huma Therapeutics announces the appointment of Shahram Sharif as Chief Business Officer - Medtech to further strengthen the success it has been having in the medical devices market.

Sharif is the former CEO and Founder of LindaCare, which specialises in remote cardiac monitoring software and tech-enabled remote care services. He joins Huma to lead the company’s business development activities for its digital companion app product. During his time at LindaCare, Sharif worked closely with global medical device companies including Philips, Boston Scientific and Medtronic. He will be drawing upon this expertise to build Huma’s relationships with potential partners and customers in the medical device sector.

Huma’s technology is used in the UK, Europe, US, Asia and Middle East to power ‘hospitals at home’ and decentralized clinical trials. It is also used internationally as companion apps that support musculoskeletal, diabetes, perioperative and robotic surgery patients.

There is rapidly increasing demand for Huma’s digital-first services as the medtech industry sees how it can drive patient engagement and adherence, and collect real-time data and real-world evidence. The demand is fuelled by multiple accolades for Huma’s remote patient monitoring platform1, including ‘pharma’s Nobel Prize’ - the Prix Galien USA 2021 Award for Best Digital Health Product - and how simple it is to use, which led to it being selected as a finalist in Fast Company’s 2021 Innovation by Design Awards.

Having partnered with leading companies such as Smith+Nephew, Boston Scientific, Bayer, Hitachi, Samsung and Atos2,3,4,5,6, Huma is now looking to match the enthusiasm shown by its clients and roll out its digital companion and software as a medical device (SaMD) offerings more widely.

Dan Vahdat, CEO & Founder of Huma, says: “We are making strides to transform healthcare and research through remote patient monitoring and the collection of real-world evidence. Over the past year, we have seen significant growth in demand for our technology to be used in digital companion apps and SaMD. Shahram’s extensive experience in the field of remote patient monitoring, software and digital companion tools in the medical device market will help us meet this demand and we are delighted to welcome him to Huma.

“At Huma, our team is our greatest strength, so we are focused on hiring experts like Shahram who share our passion for helping people live longer, fuller lives using technology.”

Sharif adds: “I’m impressed by Huma’s modular technology platform and see the potential for reliable products to be configured and scaled across healthcare and research, in partnership with medtech companies. Crucially, Huma’s platform is also a delight to use and receives incredible feedback from patients, participants and clinicians alike. I’ve seen the impact digital companions can have, transforming people’s lives and giving them support, control and empowerment again.

“The medical device industry is on the cusp of a major digital transformation, and Huma is committed to enabling visionary players in the industry to stay ahead of the MedTech 3.0 curve.”


1 Selection of awards won in 2021: Prix Galien USA 2021, LaingBuisson, UKTech Awards, Deloitte’s Fast50, HSJ Value Award

2 Smith+Nephew and Huma develop RPM app to assist the restart of UK orthopaedic surgery

3 Huma partnered with Boston Scientific to measure and improve outcomes for diseases such as Venous Leg Ulcers across the NHS and other healthcare providers

4 Huma collaborates with Bayer to advance precision treatment for lung cancer

5 Atos and Huma support Symbiosis hospital to expand care capacity

6 Meet our exceptional partners

About Huma

Huma is a global digital health technology company that exists to help people live longer, fuller lives. Our modular platform supports digital 'hospital at home' for a range of use cases across different disease areas and in life sciences we power some of the world's largest decentralized clinical trials and studies. We use digital biomarkers, predictive algorithms and real-world data from continuous patient monitoring to advance proactive, predictive care.

Our 'hospitals at home' help care for patients across the England NHS, Wales, Germany, and the UAE — evidence shows our technology can help double clinical capacity, reduce readmission rates by a third, and reduce costs whilst providing safe, high-quality care.

As part of our work to help countries hit by Covid-19, we offer digital services, not-for-profit, to national governments and have shipped over a million devices that complement our 'hospitals at home' to help power them. We are using the same technology platform to support decentralized clinical trials.